Ibio Inc (NYSE American:IBIO)
| 1.50 BATS BZX Real-Time Price As of Nov 28 |  +0.01 / +0.67%Today’s Change | 1.46 Today|||52-Week Range 24.45 | -89.07% Year-to-Date |
Latest IBIO News | Press Releases
No recent news for Ibio Inc.
Today’s Trading
| Previous close | 1.49 |
| Today’s open | 1.58 |
| Day’s range | 1.50 - 1.59 |
| Volume | 14,212 |
| Average volume (3 months) | 116,121 |
| Market cap | $14.6M |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -92.66% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +0.51% |
| P/E ratio | NM |
| Price/Sales | 24.15 |
| Price/Book | 0.22 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | February 14, 2023 |
| EPS forecast (this quarter) | -$9.97 |
| Annual revenue (last year) | $2.4M |
| Annual profit (last year) | -$50.3M |
| Net profit margin | -2,110.91% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Bryan, Texas |
Forecasts
